Incorporating technical risk in compound real option models to value a pharmaceutical R&D licensing opportunity

Research Policy

Volumn 40, Issue 9, 2011, Pages 1200-1216

  Cassimon, D ^a,f   De Backer, M ^b   Engelen, P J ^c,d,f   Van Wouwe, M ^a,f   Yordanov, V ^e,f  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b JOHNSON AND JOHNSON   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

^d Tjalling C Koopmans Research Institute   (Netherlands)

^e Vienna   (Austria)

^f RODEO Research Centre   (Belgium)

Author keywords

Case study; Compound option model; Pharmaceutical R D; Real options; Technical risk

Indexed keywords

CLOSED FORM SOLUTIONS; COMPOUND OPTION MODEL; DRUG DEVELOPMENT; EXTENDED MODEL; PHARMACEUTICAL INDUSTRY; REAL OPTION MODELS; REAL OPTIONS; RISK MEASURES; TECHNICAL RISKS; THEORETICAL MODELS;

RISK ASSESSMENT;

EID: 80053988626     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respol.2011.05.020     Document Type: Article

References (44)

1. M. Amran, and N. Kulatilaka Real Options Managing Strategic Investment in an Uncertain World 1999 Harvard Business School Press Boston, MA
2. T. Arnold, and R. Shockley Value creation at Anheuser-Busch: a real options example Journal of Applied Corporate Finance 14 2001 52 61
3. M. Benaroch, and R.J. Kauffman Justifying electronic banking network expansion using real options analysis MIS Quarterly 24 2000 197 225
4. M. Brach, and D. Paxson A gene to drug venture: poisson options analysis R&D Management 31 2001 203 214 (Pubitemid 33279316)
5. D. Cassimon, P.J. Engelen, L. Thomassen, and M. Van Wouwe The valuation of a NDA using a 6-fold compound option Research Policy 33 2004 41 51
6. D. Chance Essays in Derivatives 1998 Frank J. Fabozzi Associates New Hope, Pennsylvania
7. N. Chriss Black-Scholes and Beyond 1997 McGraw-Hill New York
8. G. Cortazar, E. Schwartz, and J. Casassus Optimal exploration investments under price and geological-technical uncertainty: a real options model D. Paxson, Real R&D Options 2003 Butterworth-Heinemann Oxford 149 165
9. J. Cox, S. Ross, and M. Rubenstein Option pricing: a simplified approach Journal of Financial Economics 7 1979 229 264
10. J. DiMasi Risks in new drug development: approval success rates for investigational drugs Clinical Pharmacology & Therapeutics 69 2001 297 307
11. A. Dixit, and R. Pindyck Investment Under Uncertainty 1994 Princeton University Press Princeton, NJ
12. R. Doctor, D. Newton, and A. Pearson Managing uncertainty in research and development Technovation 21 2001 79 90 (Pubitemid 32030324)
13. M. Elmquist, and P. Le Masson The value of a 'failed' R&D project: an emerging evaluation framework for building innovative capabilities R&D Management 39 2009 136 151
14. R. Geske The valuation of compound options Journal of Financial Economics 7 1979 63 81
15. M. Hartmann, and A. Hassan Application of real option analysis for pharmaceutical R&D project evaluation - empirical results from a survey Research Policy 35 2006 343 354
16. W. Jacob, and Y. Kwak In search of innovative techniques to evaluate pharmaceutical R&D projects Technovation 23 2005 291 296
17. K. Jensen, and P. Warren The use of options theory to value research in the service sector R&D Management 31 2001 173 180 (Pubitemid 33279313)
18. D. Kellogg, and J.M. Charnes Real-options valuation for a biotechnology company Financial Analysts Journal 56 2000 76 84
19. J. Lee, and D. Paxson Valuation of R&D real American sequential exchange options R&D Management 31 2001 191 201 (Pubitemid 33707317)
20. O. Lint, and E. Pennings An option approach to the new product development process: a case study at Philips Electronics R&D Management 31 2001 163 172
21. C.H. Loch, and K. Bode-Greuel Evaluating growth options as sources of value for pharmaceutical research projects R&D Management 31 2001 231 248
22. F. Longstaff, and E. Schwartz Valuing American options by simulation: a simple least-square approach Review of Financial Studies 14 2001 113 147 (Pubitemid 33587386)
23. S. Myers Finance theory and financial strategy Interfaces 14 1984 126 137
24. D. Newton, and A. Pearson Application of option pricing theory to R&D R&D Management 24 1994 83 89
25. D. Newton, D. Paxson, and M. Widdicks Real R&D options International Journal of Management Reviews 5/6 2004 113 130 (Pubitemid 39507999)
26. N. Nicols Scientific management at Merck: an interview with CFO Judy Lewent Harvard Business Review 72 1994 89 99
27. Ott, S.; 1992. Valuing and Timing R&D Using a Real Options Pricing Framework; Including an Application to the Development of Lunar Helium-3 Fusion. PhD Dissertation, Wisconsin University, Madison, WI, USA.
28. D. Paxson Genzyme biosurgery: a virtual real R&D option case D. Paxson, Real R&D Options 2003 Butterworth-Heinemann Oxford 271 290
29. E. Pennings, and O. Lint The option value of advanced R&D European Journal of Operational Research 103 1997 83 94
30. M. Perlitz, T. Peske, and R. Schrank Real options valuation: the new frontier in R&D project evaluation? R&D Management 29 1999 255 270
31. G. Petsko When failure should be the option BMC Biology 8 2010 61 63
32. R. Pindyck Investments of uncertain cost Journal of Financial Economics 34 1993 53 76
33. E. Schwartz Patents and R&D as real options Economic Notes 33 2004 23 54
34. E. Schwartz, and M. Moon Rational pricing of Internet companies Financial Analysts Journal 56 2000 62 75
35. E. Schwartz, and M. Moon Evaluating research and development investments M. Brennan, L. Trigeorgis, Project Flexibility, Agency, and Competition 2000 Oxford University Press New York 85 106
36. E. Schwartz, and M. Moon Rational pricing of Internet companies revisited The Financial Review 36 2001 7 26
37. E. Schwartz, and C. Zozaya-Gorostiza Investment under uncertainty in information technology: acquisition and development projects Management Science 49 2003 57 70
38. P. Sharpe, and T. Keelin How SmithKline Beecham makes better resource-allocation decisions Harvard Business Review 76 1998 45 57
39. R. Shockley An Applied Course in Real Option Valuation 2007 Thomson South-Western Mason
40. R. Shockley, S. Curtis, J. Jafari, and K. Tibbs The option value of an early-stage biotechnology investment Journal of Applied Corporate Finance 15 2003 44 55
41. Silverman, D.; 1999. Solution of the Black Scholes Equation Using the Green's Function of the Diffusion Equation. Online at: http://www.physics.uci. edu/∼silverma/bseqn/bs/bs.html.
42. L. Tartaglia, and L. Babiss Repositioning's role in drug discovery and development Drug Discovery World 7 2006 9 15
43. L. Trigeorgis Real Options 1996 MIT Press
44. B. Willigers, and J. Hansen Project valuation in the pharmaceutical industry: a comparison of least-squares Monte Carlo real option valuation and conventional approaches R&D Management 38 2008 520 537